v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Equity Attributable to Common Shareholders
Common Shares
Additional Paid In Capital
Cumulative Net (Deficit) Income
Cumulative Other Comprehensive Gain (Loss)
Cumulative Common Distributions
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     66,144,308          
Beginning balance at Dec. 31, 2024 $ 1,009,330 $ 562,019 $ 661 $ 1,017,382 $ (86,473) $ (1,065) $ (368,486) $ 447,311
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (31,169) (21,532)     (21,532)     (9,637)
Share grants, repurchases and forfeitures (in shares)     (604)          
Share grants, repurchases and forfeitures 245 245   245        
Distributions to common shareholders (661) (661)         (661)  
Other comprehensive gain (loss) (802) (546)       (546)   (256)
Distributions to noncontrolling interests (30)             (30)
Ending balance (in shares) at Mar. 31, 2025     66,143,704          
Ending balance at Mar. 31, 2025 976,913 539,525 $ 661 1,017,627 (108,005) (1,611) (369,147) 437,388
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (30,394) (21,310)     (21,310)     (9,084)
Share grants, repurchases and forfeitures (in shares)     192,295          
Share grants, repurchases and forfeitures 849 849 $ 2 847        
Distributions to common shareholders (662) (662)         (662)  
Other comprehensive gain (loss) 1,058 712       712   346
Ending balance (in shares) at Jun. 30, 2025     66,335,999          
Ending balance at Jun. 30, 2025 $ 947,764 519,114 $ 663 1,018,474 (129,315) (899) (369,809) 428,650
Beginning balance (in shares) at Dec. 31, 2025 66,653,129   66,653,129,000          
Beginning balance at Dec. 31, 2025 $ 900,698 489,697 $ 667 1,018,985 (152,660) (836) (376,459) 411,001
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (17,859) (9,427)     (9,427)     (8,432)
Share grants, repurchases and forfeitures (in shares)     12,921,000          
Share grants, repurchases and forfeitures 349 349   349        
Distributions to common shareholders (3,333) (3,333)         (3,333)  
Other comprehensive gain (loss) 3,986 2,432       2,432   1,554
Distributions to noncontrolling interests (150)             (150)
Ending balance (in shares) at Mar. 31, 2026     66,666,050,000          
Ending balance at Mar. 31, 2026 $ 883,691 479,718 $ 667 1,019,334 (162,087) 1,596 (379,792) 403,973
Beginning balance (in shares) at Dec. 31, 2025 66,653,129   66,653,129,000          
Beginning balance at Dec. 31, 2025 $ 900,698 489,697 $ 667 1,018,985 (152,660) (836) (376,459) 411,001
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Distributions to common shareholders $ (6,666)              
Ending balance (in shares) at Jun. 30, 2026 66,762,231   66,762,231,000          
Ending balance at Jun. 30, 2026 $ 841,168 461,660 $ 668 1,020,667 (176,550) 0 (383,125) 379,508
Beginning balance (in shares) at Mar. 31, 2026     66,666,050,000          
Beginning balance at Mar. 31, 2026 883,691 479,718 $ 667 1,019,334 (162,087) 1,596 (379,792) 403,973
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (23,088) (14,463)     (14,463)     (8,625)
Share grants, repurchases and forfeitures (in shares)     96,181,000          
Share grants, repurchases and forfeitures 1,334 1,334 $ 1 1,333        
Distributions to common shareholders (3,333) (3,333)         (3,333)  
Other comprehensive gain (loss) (2,616) (1,596)       (1,596)   (1,020)
Distributions to noncontrolling interests $ (14,820)             (14,820)
Ending balance (in shares) at Jun. 30, 2026 66,762,231   66,762,231,000          
Ending balance at Jun. 30, 2026 $ 841,168 $ 461,660 $ 668 $ 1,020,667 $ (176,550) $ 0 $ (383,125) $ 379,508